Literature DB >> 12227107

[Craniocerebral trauma--new pathophysiological and therapeutic viewpoints].

B Schaller1.   

Abstract

AIM: The prognosis has markedly improved during the last years after mild and moderate head injuries. After severe head trauma, this evolution could not be observed so far. This requires a better understanding of pathophysiological interaction, especially in the subacute and late phase of trauma.
METHODS: Review article. DISCUSSION: Causes for the development of secondary brain damage are the intracranial space demand after traumatic injury and edema formation which max result in ischemia, as well as inflammatory processes. Both isolated severe head trauma and polytrauma with or without brain damage may result in a systemic inflammatory response syndrome due to the synthesis of cytokines and other inflammatory mediators which may cause a single or multiple organ failure. The hypermetabolism after severe head trauma is often regarded as an interaction between the central nervous system and the whole organism by the activation of the neuroendocrine axis. Moreover, coagulation, metabolism and fracture healing are influenced by the onset of SIRS as well.
CONCLUSION: Our knowledge about the bidirectional inflammatory interaction between brain and whole organism is still limited. It is generally accepted that extracranial complications are highly influential in determining the outcome from severe head injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227107     DOI: 10.1024/1023-9332.8.4.145

Source DB:  PubMed          Journal:  Swiss Surg        ISSN: 1023-9332


  4 in total

Review 1.  [Cerebellopontine angle surgery. Part 2: Specific remarks].

Authors:  B Schaller
Journal:  HNO       Date:  2003-03-28       Impact factor: 1.284

Review 2.  Role of colloids in traumatic brain injury: Use or not to be used?

Authors:  Tumul Chowdhury; Ronald B Cappellani; Bernhard Schaller; Jayesh Daya
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-07

3.  Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.

Authors:  Leonardo Lorente; María M Martín; Patricia López; Luis Ramos; José Blanquer; Juan J Cáceres; Jordi Solé-Violán; Jorge Solera; Judith Cabrera; Mónica Argueso; Raquel Ortiz; María L Mora; Santiago Lubillo; Alejandro Jiménez; Juan M Borreguero-León; Agustín González; Josune Orbe; José A Rodríguez; José A Páramo
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

Review 4.  New Prognostic Biomarkers in Patients With Traumatic Brain Injury.

Authors:  Leonardo Lorente
Journal:  Arch Trauma Res       Date:  2015-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.